Giancarlo Vecchio
Biographic Data
| ID | 7604460 |
|---|---|
| NAME | Giancarlo Vecchio |
| GIVEN NAMES | Giancarlo |
| FAMILY NAME | Vecchio |
| SIGNATURE | VECCHIO G |
| AFFILIATIONS | Ospedale Pediatrico Giovanni XXIII |
| ORCID | 0000-0001-5462-0027 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
An Epidemic of Parvovirus B19-Induced Aplastic Crises in Pediatric Patients with Hereditary Spherocytosis Following the Covid-19 Pandemic
Background: Parvovirus B19 is the major cause of transient aplastic crisis in children with hereditary spherocytosis (HS) inhibiting erythropoiesis and leading to a severe drop in hemoglobin levels, requiring hospitalization and transfusional support. During the COVID-19 pandemic, the circulation of non-COVID respiratory viruses, such as parvovirus B19, initially declined but subsequently increased abruptly following the relaxation of containment…
Successful Eltrombopag Therapy in a Child with MYH9-Related Inherited Thrombocytopenia
Inherited thrombocytopenias represents a heterogenous group of diseases characterized by a congenital reduction in the platelet count that could lead to a bleeding tendency. MYH9-related disorders are characterized by large platelets and congenital thrombocytopenia. Thrombopoietin-receptor agonists: eltrombopag and romiplostim are currently approved in many countries for the treatment of different forms of acquired thrombocytopenia, such as immun…
No prominent works on this page.
Successful Eltrombopag Therapy in a Child with MYH9-Related Inherited Thrombocytopenia
Inherited thrombocytopenias represents a heterogenous group of diseases characterized by a congenital reduction in the platelet count that could lead to a bleeding tendency. MYH9-related disorders are characterized by large platelets and congenital thrombocytopenia. Thrombopoietin-receptor agonists: eltrombopag and romiplostim are currently approved in many countries for the treatment of different forms of acquired thrombocytopenia, such as immun…
An Epidemic of Parvovirus B19-Induced Aplastic Crises in Pediatric Patients with Hereditary Spherocytosis Following the Covid-19 Pandemic
Background: Parvovirus B19 is the major cause of transient aplastic crisis in children with hereditary spherocytosis (HS) inhibiting erythropoiesis and leading to a severe drop in hemoglobin levels, requiring hospitalization and transfusional support. During the COVID-19 pandemic, the circulation of non-COVID respiratory viruses, such as parvovirus B19, initially declined but subsequently increased abruptly following the relaxation of containment…
Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · 2019-20 coronavirus outbreak (1 works) · Biology (1 works) · Blood groups and transfusion (1 works) · Coronavirus disease 2019 (COVID-19 (1 works) · Dermatological and COVID-19 studies (1 works) · Disease (1 works) · Eltrombopag (1 works)